H. Ishizaki

发表

A Case of Liver Metastasis that Developed 19 Months and 135 Months after a Curative Resection of Sigmoid Colon Cancer

T. Nishida, K. Chijiiwa, N. Imamura, 2014 .

Suppression of choroidal neovascularization by vaccination with epitope peptide derived from human VEGF receptor 2 in an animal model.

H. Tahara, Y. Tamaki, Y. Yanagi, 2008, Investigative ophthalmology & visual science.

Frequency of CD4+CD161+ T Cell and Interleukin-10 Expression in Inflammatory Bowel Diseases

N. Choijookhuu, Y. Hishikawa, Baatarsuren Batmunkh, 2017, Acta Histochemica et Cytochemica.

Laparoscopic anterior pelvic exenteration for locoregionally advanced rectal cancer directly invading the urinary bladder: A case report of low anterior resection with en bloc cystectomy for sphincter preservation

T. Kamoto, T. Nishida, S. Mukai, 2015, Asian journal of endoscopic surgery.

Enhancement of cancer vaccine therapy by systemic delivery of a tumor-targeting Salmonella-based STAT3 shRNA suppresses the growth of established melanoma tumors.

M. Hensel, E. Manuel, D. Diamond, 2011, Cancer research.

Inhibition of Tumor Growth with Antiangiogenic Cancer Vaccine Using Epitope Peptides Derived from Human Vascular Endothelial Growth Factor Receptor 1

M. Shibuya, T. Tsunoda, H. Tahara, 2006, Clinical Cancer Research.

High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer

S. Ishikawa, D. Komura, M. Izumizaki, 2020, PloS one.

Phase II clinical trial of peptide cocktail therapy for patients with advanced pancreatic cancer: VENUS‐PC study

Yusuke Nakamura, M. Oka, H. Nagano, 2016, Cancer science.

Recombinant Modified Vaccinia Virus Ankara (MVA) Expressing Wild-Type Human p53 Induces Specific Antitumor CTL Expansion

D. Diamond, S. Lacey, J. Ellenhorn, 2011, Cancer investigation.

Heterologous Prime/Boost Immunization With p53-based Vaccines Combined With Toll-like Receptor Stimulation Enhances Tumor Regression

V. Shahabi, E. Manuel, D. Diamond, 2010, Journal of immunotherapy.

Predictive biomarkers for the efficacy of peptide vaccine treatment: based on the results of a phase II study on advanced pancreatic cancer

Yusuke Nakamura, M. Oka, H. Nagano, 2017, Journal of experimental & clinical cancer research : CR.

Modified vaccinia Ankara expressing survivin combined with gemcitabine generates specific antitumor effects in a murine pancreatic carcinoma model

E. Manuel, D. Diamond, J. Ellenhorn, 2010, Cancer Immunology, Immunotherapy.

Clinicopathological features, postoperative survival and prognostic variables for cancer-related survival in patients with mucinous colorectal carcinoma

K. Chijiiwa, S. Uchiyama, N. Maehara, 2015, Surgery Today.

Neutrophil-to-Lymphocyte Ratio and Intratumoral CD45RO-Positive T Cells as Predictive Factors for Longer Survival of Patients with Colorectal Liver Metastasis after Hepatectomy.

A. Nanashima, H. Kataoka, K. Yano, 2020, The Tohoku journal of experimental medicine.

A Case of Anal Canal Adenocarcinoma Originating from Crypt Glands Accompanied with Pagetoid Spread without Macroscopic Tumor Lesions in the Anorectum

K. Tsuchiya, S. Minami, A. Nanashima, 2016 .